Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline CEO: Chin up, investors. Dividend's safe, and Novartis deal awaits
GlaxoSmithKline CEO: Chin up, investors. Dividend's safe, and Novartis deal awaits
GlaxoSmithKline CEO: Chin up, investors. Dividend's safe, and Novartis deal awaits
Submitted by
admin
on December 18, 2014 - 4:06pm
Source:
Fierce Pharma
News Tags:
GSK
Pharma CEOs
Novartis
dividends
Andrew Witty
Headline:
GlaxoSmithKline CEO: Chin up, investors. Dividend's safe, and Novartis deal awaits
Do Not Allow Advertisers to Use My Personal information
